Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Fosravuconazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,090Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    27/02/2026 Eisai
    Japan
    		 Eisai Co., Ltd. 230MF10083 Fosravuconazole L-lysine ethanolate 2018-07-09 2018-07-09 4-6-10 Koishikawa, Bunkyo-ku, Tokyo
    27/02/2026 Eisai
    Japan
    		 EISAI PHARMACEUTICALS INDIA PVT LTD 228MF10209 Fosravuconazole L-lysine ethanolate 2016-11-09 2016-11-09 Ramky Pharma City (SEZ), Plot Nos. 96,97,98,124 & 126, Parawada-531 019, Visakhapatnam District, A. P. , India
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.